Imitation of the Medical Hospice Model and the Emergence of Competitors
First written in FY2019. 15 of 16 entries say "Restated". Latest entry: FY2026-H1.
2 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding the risks of imitation of the Ishinkan model and the emergence of competitors. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2023-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2022-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2021RestatedAnnual report
「The business scheme (model) itself is not protected by patents or other rights, making it difficult to establish legal protections against imitation by other companies, and creating a risk that operators offering services similar to those of this business will emerge.」
The company continues to describe the risks of imitation of the Ishinkan model and the emergence of competitors. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The company provides an overall statement that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2020RestatedAnnual report
「The business scheme (model) itself is not protected by patents or other rights, making it difficult to establish legal protections against imitation by other companies, and creating a risk that operators offering services similar to those of this business will emerge.」
The company continues to describe the risks of imitation of the Ishinkan model and the emergence of competitors. - FY2020-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」
The company states that there have been no material changes regarding imitation of the Ishinkan model and the emergence of competitors. - FY2019First statedAnnual report
「The business scheme (model) itself is not protected by patents or other rights, making it difficult to establish legal protections against imitation by other companies, and creating a risk that operators offering services similar to those of this business will emerge.」
The company identifies its relationships with medical and administrative institutions, operational expertise tailored to local needs, and ability to recruit nursing staff as substantive differentiating factors, and plans to respond by expanding its user base and adding peripheral businesses.